Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.67B.
ENTERPRISE VALUE (EV)
$1.67B
Zenas BioPharma, Inc.
Market Cap
$1.70B
Enterprise Value (EV)
$1.67B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Zenas BioPharma, Inc. (ZBIO) | $1.70B | $1.67B |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | $3.78B |
| Personalis, Inc. (PSNL)vs › | $1.71B | $1.66B |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.73B | $1.70B |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.74B | $1.37B |
| Xeris Biopharma Holdings, Inc. (XERS)vs › | $1.74B | $1.91B |
| Absci Corporation (ABSI)vs › | $1.74B | $1.64B |
| Novocure Ltd (NVCR)vs › | $1.74B | $1.88B |
| Surgery Partners, Inc. (SGRY)vs › | $1.75B | $5.55B |
| Generate Biomedicines, Inc. (GENB)vs › | $1.77B | $1.70B |
Market Cap
$1.70B
Total Debt
$79.75M
Cash
$110.64M
Enterprise Value
$1.67B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
